X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
index medicus (39) 39
male (25) 25
hematology (22) 22
female (21) 21
middle aged (19) 19
oncology (19) 19
abridged index medicus (16) 16
lymphoma, large b-cell, diffuse - genetics (16) 16
prognosis (14) 14
cancer (13) 13
expression (13) 13
adult (12) 12
aged (12) 12
in situ hybridization, fluorescence (12) 12
aged, 80 and over (11) 11
b-cell lymphoma (10) 10
genetics & heredity (10) 10
mutation (10) 10
adolescent (9) 9
cell line, tumor (8) 8
lymphoma, large b-cell, diffuse - drug therapy (8) 8
rituximab (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
lymphoma, b-cell - genetics (7) 7
elderly-patients (6) 6
gene (6) 6
gene expression profiling (6) 6
hemic and lymphatic diseases (6) 6
immunohistochemistry (6) 6
lymphoid neoplasia (6) 6
proto-oncogene proteins c-myc - genetics (6) 6
survival (6) 6
translocation, genetic (6) 6
young adult (6) 6
c-myc (5) 5
follicular lymphoma (5) 5
gene expression regulation, neoplastic (5) 5
genetic aspects (5) 5
karyotyping (5) 5
lymphoma, follicular - genetics (5) 5
lymphoma, large b-cell, diffuse - metabolism (5) 5
lymphoma, large b-cell, diffuse - pathology (5) 5
lymphomas (5) 5
mediastinal neoplasms - genetics (5) 5
pathology (5) 5
proto-oncogene proteins c-bcl-2 - genetics (5) 5
translocation (5) 5
acute myeloid-leukemia (4) 4
biomarkers, tumor - genetics (4) 4
chromosome aberrations (4) 4
cohort studies (4) 4
complex (4) 4
diagnosis (4) 4
disease-free survival (4) 4
doxorubicin (4) 4
gene expression (4) 4
genome (4) 4
genomes (4) 4
hodgkin disease - genetics (4) 4
hodgkin lymphoma (4) 4
immune system diseases (4) 4
lymphoma, large b-cell, diffuse - mortality (4) 4
multivariate analysis (4) 4
mutation - genetics (4) 4
mutations (4) 4
myelodysplastic syndromes - genetics (4) 4
non-hodgkins-lymphoma (4) 4
nuclear proteins - genetics (4) 4
recurrent (4) 4
rituximab plus cyclophosphamide (4) 4
somatic mutations (4) 4
survival analysis (4) 4
t-cells (4) 4
translocation, genetic - genetics (4) 4
treatment outcome (4) 4
vincristine (4) 4
aberrations (3) 3
acute lymphoblastic-leukemia (3) 3
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
b-lymphocytes - metabolism (3) 3
b7-h1 antigen - genetics (3) 3
base sequence (3) 3
biopsy (3) 3
burkitt lymphoma - genetics (3) 3
chemotherapy (3) 3
chromosomes, artificial, bacterial (3) 3
chromosomes, human, pair 12 - genetics (3) 3
classical hodgkin lymphoma (3) 3
cyclophosphamide - therapeutic use (3) 3
development and progression (3) 3
dna mutational analysis (3) 3
doxorubicin - therapeutic use (3) 3
fluorescence in situ hybridization (3) 3
follow-up studies (3) 3
gene deletion (3) 3
gene knockdown techniques (3) 3
gene mutations (3) 3
gene-expression (3) 3
genes (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 03/2011, Volume 471, Issue 7338, pp. 377 - +
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2012, Volume 30, Issue 28, pp. 3452 - 3459
Journal Article
Nature, ISSN 0028-0836, 08/2011, Volume 476, Issue 7360, pp. 298 - 303
Journal Article
The Journal of Pathology, ISSN 0022-3417, 06/2015, Volume 236, Issue 2, pp. 136 - 141
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 4, pp. 329 - 335
Journal Article
PLoS Medicine, ISSN 1549-1277, 12/2016, Volume 13, Issue 12, pp. e1002197 - e1002197
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 692 - 700
Journal Article
Journal Article
Journal Article
Journal Article
Modern Pathology, ISSN 0893-3952, 12/2011, Volume 24, Issue 12, pp. 1586 - 1597
The term gray zone lymphoma has been applied to tumors that demonstrate transitional morphologic and immunophenotypic features between classical Hodgkin's... 
large B-cell lymphoma | fluorescence in situ hybridization (FISH) | chromosomal aberrations | gray zone lymphoma | mediastinal lymphoma | oncogenes | immunohistochemistry | Hodgkin lymphoma | REED-STERNBERG CELLS | IMMUNOGLOBULIN | PATHOLOGY | GENOMIC IMBALANCES | FEATURES | B-CELL LYMPHOMA | GAINS | AMPLIFICATION | RECURRENT | DISEASE | CLASSICAL HODGKIN LYMPHOMA | Immunohistochemistry | Mediastinal Neoplasms - genetics | Prognosis | Hodgkin Disease - genetics | Hodgkin Disease - pathology | Humans | Mediastinal Neoplasms - classification | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Young Adult | Aged, 80 and over | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Lymphoma - pathology | Mediastinal Neoplasms - immunology | Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Biomarkers, Tumor - analysis | Hodgkin Disease - classification | Lymphoma - immunology | Lymphoma - genetics | Immunophenotyping | In Situ Hybridization, Fluorescence | Mediastinal Neoplasms - pathology | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Chromosome Aberrations | Hodgkin Disease - immunology | Aged | Lymphoma, Large B-Cell, Diffuse - genetics | Statistical analysis | Data processing | Myc protein | CIITA protein | Janus kinase 2 | Fluorescence in situ hybridization | Cyclin E | chromosome 16 | Age | Chromosome aberrations | Hodgkin's disease | B-cell lymphoma | Tumors | Index Medicus
Journal Article